3 SEHK Growth Companies With High Insider Ownership To Consider

The Hong Kong market has experienced a significant boost, with the Hang Seng Index gaining 13% following China’s announcement of robust stimulus measures aimed at revitalizing its economy. This positive sentiment has created an optimistic environment for growth companies on the Stock Exchange of Hong Kong (SEHK), especially those with high insider ownership, which can indicate confidence in the company’s prospects and alignment with shareholder interests. In such a climate, identifying stocks that combine growth potential with strong insider commitment can be particularly appealing to investors seeking opportunities in this vibrant market.

Top 10 Growth Companies With High Insider Ownership In Hong Kong

Name

Insider Ownership

Earnings Growth

Laopu Gold (SEHK:6181)

36.4%

32.7%

Akeso (SEHK:9926)

20.5%

54.6%

Fenbi (SEHK:2469)

33.1%

22.4%

Zylox-Tonbridge Medical Technology (SEHK:2190)

18.8%

69.8%

Pacific Textiles Holdings (SEHK:1382)

11.2%

37.7%

Zhejiang Leapmotor Technology (SEHK:9863)

15%

69.7%

DPC Dash (SEHK:1405)

38.1%

104.2%

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)

13.9%

109.2%

Beijing Airdoc Technology (SEHK:2251)

29.1%

93.4%

Kindstar Globalgene Technology (SEHK:9960)

16.5%

88%

Click here to see the full list of 48 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener.

Let’s dive into some prime choices out of the screener.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: BYD Company Limited, along with its subsidiaries, operates in the automobiles and batteries sectors across the People’s Republic of China, Hong Kong, Macau, Taiwan, and internationally with a market cap of approximately HK$941.02 billion.

Operations: The company’s revenue primarily comes from its Automobiles and Related Products and Other Products segment, generating CN¥507.52 billion, followed by the Mobile Handset Components, Assembly Service and Other Products segment with CN¥154.49 billion.

Insider Ownership: 30.1%

Earnings Growth Forecast: 15.5% p.a.

BYD has demonstrated strong growth with earnings up 36.2% over the past year and forecasted revenue growth of 14.2% annually, outpacing the Hong Kong market. The company trades at a significant discount to its estimated fair value, indicating potential investment appeal. Recent production and sales increases highlight robust operational performance, while strategic partnerships like the one with Uber aim to enhance global EV adoption and further expand BYD’s market presence.

SEHK:1211 Earnings and Revenue Growth as at Oct 2024

SEHK:1211 Earnings and Revenue Growth as at Oct 2024

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Meituan is a technology retail company in China, with operations spanning various services including food delivery and travel booking, and has a market cap of approximately HK$1.22 trillion.

Operations: The company’s revenue is primarily derived from Core Local Commerce, generating CN¥228.13 billion, and New Initiatives, contributing CN¥77.56 billion.

Insider Ownership: 11.8%

Earnings Growth Forecast: 26% p.a.

Meituan’s recent performance showcases robust growth, with earnings rising by 175.5% over the past year and revenue expected to grow at 12.9% annually, surpassing the Hong Kong market average. The company is trading at a discount to its estimated fair value, suggesting potential investment appeal. Despite limited insider buying recently, Meituan has been actively repurchasing shares worth HK$7.17 billion this year, reflecting confidence in its long-term prospects.

SEHK:3690 Earnings and Revenue Growth as at Oct 2024

SEHK:3690 Earnings and Revenue Growth as at Oct 2024

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Adicon Holdings Limited operates medical laboratories in the People’s Republic of China and has a market cap of HK$5.98 billion.

Operations: The company generates revenue of CN¥3.12 billion from its Healthcare Facilities & Services segment.

Insider Ownership: 22.4%

Earnings Growth Forecast: 23.2% p.a.

Adicon Holdings, recently added to the S&P Global BMI Index, shows promising growth prospects with earnings expected to grow significantly at 23.2% annually over the next three years, outpacing the Hong Kong market. Despite a recent decline in half-year sales and net income, analysts anticipate a 36.2% stock price increase. Revenue is projected to rise by 11.7% annually, exceeding market expectations but below the significant growth threshold of 20%.

SEHK:9860 Earnings and Revenue Growth as at Oct 2024

SEHK:9860 Earnings and Revenue Growth as at Oct 2024

Next Steps

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include SEHK:1211 SEHK:3690 and SEHK:9860.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Go to Source